Justicidin A
Based on 1 Customer Validation
justicidin A is a nature product that could be isolated form Justicia procumbens. justicidin A decreases the level of Ku70 leading to translocation of Bax from the cytosol to mitochondria to induce apoptosis. justicidin A can be used in research of cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.75%
- CAS No.: 25001-57-4
- 화학식: C22H18O7
- 분자량:394.37
-
보관:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Biological Activity
제품 설명
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Ca-Ski | ED50 |
3 ng/mL
Compound: 5
|
Cytotoxicity against human CaSki cells after 6 days by MTT assay
Cytotoxicity against human CaSki cells after 6 days by MTT assay
|
[PMID: 10425143] |
| Ca-Ski | ED50 |
3 x 10-3 μg/mL
Compound: 5
|
Cytotoxicity against human CaSki cells after 6 days by MTT assay
Cytotoxicity against human CaSki cells after 6 days by MTT assay
|
[PMID: 10425143] |
| Ca-Ski | ED50 |
3 ng/mL
Compound: 1
|
Cytotoxicity against human CaSKi cells by MTT assay
Cytotoxicity against human CaSKi cells by MTT assay
|
[PMID: 11908984] |
| Ca-Ski | ED50 |
3 x 10-3 μg/mL
Compound: 1
|
Cytotoxicity against human CaSKi cells by MTT assay
Cytotoxicity against human CaSKi cells by MTT assay
|
[PMID: 11908984] |
| Hep 3B2 | ED50 |
0.29 ng/mL
Compound: 1
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 11908984] |
| Hep 3B2 | ED50 |
2.9 x 10-2 μg/mL
Compound: 1
|
Cytotoxicity against human Hep3B cells by MTT assay
Cytotoxicity against human Hep3B cells by MTT assay
|
[PMID: 11908984] |
| HepG2 | ED50 |
0.2 ng/mL
Compound: 1
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 11908984] |
| HepG2 | ED50 |
2 x 10-2 μg/mL
Compound: 1
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 11908984] |
| HepG2 | IC50 |
163 μM
Compound: 2
|
Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
Cytotoxicity against Homo sapiens (human) HepG2 cells after 3 days by MTT assay
|
10.1007/s00044-009-9172-1 |
| HT-29 | IC50 |
>10 μM
Compound: 6
|
Cytotoxicity against human HT-29 cells
Cytotoxicity against human HT-29 cells
|
[PMID: 24937209] |
| HT-3 | ED50 |
1.8 ng/mL
Compound: 5
|
Cytotoxicity against human HT-3 cells after 6 days by MTT assay
Cytotoxicity against human HT-3 cells after 6 days by MTT assay
|
[PMID: 10425143] |
| HT-3 | ED50 |
1.8 x 10-3 μg/mL
Compound: 5
|
Cytotoxicity against human HT-3 cells after 6 days by MTT assay
Cytotoxicity against human HT-3 cells after 6 days by MTT assay
|
[PMID: 10425143] |
| HT-3 | IC50 |
0.0018 μg/mL
Compound: 110
|
Antiproliferative activity against human HT3 cells assessed as reduction in cell viability after 6 days by MTT assay
Antiproliferative activity against human HT3 cells assessed as reduction in cell viability after 6 days by MTT assay
|
[PMID: 30830783] |
| KB | ED50 |
<1 μg/mL
Compound: 9
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 2849640] |
| KB | ED50 |
<1 μg/mL
Compound: 1
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 3734816] |
| Platelet | IC50 |
31.7 μM
Compound: 3
|
Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich blood by turbidimetric method
Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich blood by turbidimetric method
|
[PMID: 8988600] |
| PLC-PRF-5 | ED50 |
2.2 ng/mL
Compound: 5
|
Cytotoxicity against human PLC/PRF/5 cells after 6 days by MTT assay
Cytotoxicity against human PLC/PRF/5 cells after 6 days by MTT assay
|
[PMID: 10425143] |
| PLC-PRF-5 | ED50 |
2.2 x 10-3 μg/mL
Compound: 5
|
Cytotoxicity against human PLC/PRF/5 cells after 6 days by MTT assay
Cytotoxicity against human PLC/PRF/5 cells after 6 days by MTT assay
|
[PMID: 10425143] |
| SiHa | ED50 |
7.4 ng/mL
Compound: 5
|
Cytotoxicity against human SiHa cells after 6 days by MTT assay
Cytotoxicity against human SiHa cells after 6 days by MTT assay
|
[PMID: 10425143] |
| SiHa | ED50 |
7.4 x 10-3 μg/mL
Compound: 5
|
Cytotoxicity against human SiHa cells after 6 days by MTT assay
Cytotoxicity against human SiHa cells after 6 days by MTT assay
|
[PMID: 10425143] |
| SiHa | ED50 |
7.4 ng/mL
Compound: 1
|
Cytotoxicity against human SiHa cells by MTT assay
Cytotoxicity against human SiHa cells by MTT assay
|
[PMID: 11908984] |
| SiHa | ED50 |
7.4 x 10-3 μg/mL
Compound: 1
|
Cytotoxicity against human SiHa cells by MTT assay
Cytotoxicity against human SiHa cells by MTT assay
|
[PMID: 11908984] |
| T-24 | ED50 |
2 ng/mL
Compound: 5
|
Cytotoxicity against human T24 cells after 6 days by MTT assay
Cytotoxicity against human T24 cells after 6 days by MTT assay
|
[PMID: 10425143] |
| T-24 | ED50 |
2 x 10-3 μg/mL
Compound: 5
|
Cytotoxicity against human T24 cells after 6 days by MTT assay
Cytotoxicity against human T24 cells after 6 days by MTT assay
|
[PMID: 10425143] |
In Vitro
justicidin A (0-2.5 μM; 6 days) inhibits cell growth in colorectal cancer cells with IC50 values of 0.110, 0.400, 0.020, 1.540 and 0.004 μM for HT-29, HCT 116, SiHa, MCF7 and T24 cells, respectively[1].
justicidin A (0.75 and 5 μM; 0-72 h) induces apoptosis in colorectal cancer cells[1].
justicidin A (0.75 and 5 μM; 0-72 h) induces the cleavage of caspases and their target proteins in human colorectal cancer cells[1].
justicidin A (0.75 and 5 μM; 0-72 h) damages mitochondria and releases cyto c and Smac from mitochondria[1].
justicidin A (0.75 and 5 μM; 0-96 h) decreases the level of Ku70 leading to translocation of Bax from the cytosol to mitochondria[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HT-29, HCT 116, SiHa, MCF7 and T24 cells
-
Concentration:0-2.5 μM
-
Incubation Time:6 days
-
Result:Inhibited cell growth in a dose-dependent manner.
-
Cell Line:HT-29 and HCT 116 cells
-
Concentration:0.75 μM (HT-29 cells) and 5 μM (HCT 116 cells)
-
Incubation Time:0, 12, 16, 20, 24, 48, and 72 hours
-
Result:Induced apoptosis in a time-dependent manner.
Increased the population of sub-G 1 cells in a time-dependent manner.
-
Cell Line:HT-29 and HCT 116 cells
-
Concentration:0.75 μM (HT-29 cells) and 5 μM (HCT 116 cells)
-
Incubation Time:0, 12, 16, 20, 24, 48, 72, and 96 hours
-
Result:Decreased the amount of cytosolic Ku70 in HCT 116 cells and decreased (0.6-fold) at 48 h and reached the lowest level (0.33-fold) at 96 h.
-
Cell Line:HT-29 and HCT 116 cells
-
Concentration:0.75 μM (HT-29 cells) and 5 μM (HCT 116 cells)
-
Incubation Time:0, 12, 16, 20, 24, 48, and 72 hours
-
Result:Induced the cleavage of caspases and their target proteins.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NOD-SCID mice with HT-29 cells xenograftes[1]
-
Dosage:6.2 mg/kg
-
Administration:Oral administration; daily, for 56 days
-
Result:Inhibited tumor growth and decreased tumor weight.
Chemical Information
-
CAS No. 25001-57-4
-
Appearance Solid
-
분자량 394.37
-
화학식 C22H18O7
-
Color White to off-white
-
SMILES
O=C1OCC2=C(OC)C3=CC(OC)=C(OC)C=C3C(C4=CC=C(OCO5)C5=C4)=C12
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
용액&용해도
In Vitro:
DMSO : 16.67 mg/mL (42.27 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocol
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
순도&문서
-
Data Sheet (255 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5357 mL | 12.6784 mL | 25.3569 mL | 63.3922 mL |
| 5 mM | 0.5071 mL | 2.5357 mL | 5.0714 mL | 12.6784 mL | |
| 10 mM | 0.2536 mL | 1.2678 mL | 2.5357 mL | 6.3392 mL | |
| 15 mM | 0.1690 mL | 0.8452 mL | 1.6905 mL | 4.2261 mL | |
| 20 mM | 0.1268 mL | 0.6339 mL | 1.2678 mL | 3.1696 mL | |
| 25 mM | 0.1014 mL | 0.5071 mL | 1.0143 mL | 2.5357 mL | |
| 30 mM | 0.0845 mL | 0.4226 mL | 0.8452 mL | 2.1131 mL | |
| 40 mM | 0.0634 mL | 0.3170 mL | 0.6339 mL | 1.5848 mL |